INZY Inozyme Pharma Inc
927
$4.73
$0.13
(2.83%)
| Watchers | 927 |
| 52-Wk Low | $2.69 |
| 52-Wk High | $7.80 |
| Market Cap | $284.54M |
| Volume | 306,311.00 |
| 52-Wk High | $7.80 |
| 52-Wk Low | $2.69 |
Inozyme Pharma, Inc. (NASDAQ:INZY) CEO Douglas A. Treco Sells 7,523 SharesTicker Report • about 1 month ago
Inozyme Pharma, Inc. (NASDAQ:INZY - Get Free Report) CEO Douglas A. Treco sold 7,523 shares of the business's stock in a transaction that occurred on Tuesday, April 2nd. The shares were sold at an...
Share to Feed
BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) ( Company or Inozyme ), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for...
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) ( the Company or Inozyme ), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics...
This is a signal that INZY's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that INZY's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a Bullish indicator signaling INZY's price could rise from here. Traders may explore going long the stock or buying call options...
- Company to host conference call and webcast featuring key opinion leaders on Monday, April 8, 2024 at 8:00 a.m. ET - BOSTON, March 26, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq...
Inozyme Pharma, Inc. (NASDAQ:INZY Free Report) Investment analysts at HC Wainwright issued their Q1 2024 EPS estimates for Inozyme Pharma in a report issued on Wednesday, March 13th...
Inozyme Pharma, Inc. (NASDAQ:INZY Free Report) Investment analysts at HC Wainwright cut their FY2024 EPS estimates for Inozyme Pharma in a report issued on Wednesday, March 13th...
Inozyme Pharma (NASDAQ:INZY Get Free Report)s stock had its outperform rating reissued by research analysts at Wedbush in a research report issued on Tuesday, RTT News...